Posted in | News | Medical Robotics

Accuray Launches PlanTouch Software Complementing the CyberKnife Robotic System

A radiation oncology company, Accuray, recently declared the launch of PlanTouch, radiation oncology-based fully integrated software application, which enables the physicians to review and determine the suitable method of radiation treatment for patients, remotely using an iPad.


Developed along with Ohio-based MIM Software, this new PlanTouch software simplifies the previous onsite operation involved in CyberKnife Robotic Radiosurgery System. It provides the physicians with flexibility, mobility, and convenience in order to offer high-quality patient care. The U.S. Food & Drug Administration (FDA) has offered 510(k) clearance for PlanTouch.

CyberKnife System's data management and planning software fully integrates PlanTouch's interface. This software facilitates the reviewing of contours, images, isodose curves, and dose volume histograms and with the help of an iPad, the physicians will instantly approve their treatment plans. With excellent features, this innovative mobile solution strengthens communication between the radiation oncologist and referring physicians including neurosurgeons, urologists and thoracic surgeons. The workflow of physicians has now become simpler and efficient with the introduction of this remote-featured software. Besides being provided with review capability, the new PlanTouch software also enables approving a treatment plan, which makes it stand unique among the existing tablet-based radiation oncology applications.

Specifically designed for using on the iPad, Accuray's PlanTouch is compatible with all the advanced features of iPad. Moreover, the patient’s information is kept confidential, ensuring each patient with the right assessment and treatment approval. A software license upgrade is now available for CyberKnife Systems and the app can be downloaded using Apple App Store, thereby activating PlanTouch.



Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Accuray Incorporated. (2019, February 20). Accuray Launches PlanTouch Software Complementing the CyberKnife Robotic System. AZoRobotics. Retrieved on February 28, 2024 from

  • MLA

    Accuray Incorporated. "Accuray Launches PlanTouch Software Complementing the CyberKnife Robotic System". AZoRobotics. 28 February 2024. <>.

  • Chicago

    Accuray Incorporated. "Accuray Launches PlanTouch Software Complementing the CyberKnife Robotic System". AZoRobotics. (accessed February 28, 2024).

  • Harvard

    Accuray Incorporated. 2019. Accuray Launches PlanTouch Software Complementing the CyberKnife Robotic System. AZoRobotics, viewed 28 February 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Azthena logo powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.